ArticleJAMA network open2019

Variation in the Assessment of Immune-Related Adverse Event Occurrence, Grade, and Timing in Patients Receiving Immune Checkpoint Inhibitors.

David Hsiehchen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.